Percutaneous Cryoablation for Liver Cancer

Based on the primary tumor site, liver cancer can be divided into two categories: (1) primary liver cancer and (2) metastatic cancer to the liver from a distant primary site. Guided cryoablation via many imaging methods induces iceball formation and tumor necrosisand is an attractive option for treating unresectable hepatocellular carcinoma (HCC) and metastatic liver cancer. There are several advantages to using cryoablation for the treatment of liver cancer: it can be performed percutaneously, intraoperatively, and laparoscopically; iceball formation can be monitored; it has little impact on nearby large blood vessels; and it induces a cryo-immunological response in situ. Clinically, primary research has shown that percutaneous cryoablation of liver cancer is relatively safe and efficient, and it can be combined with other methods, such as radiation therapy, chemotherapy, and immunology, to control disease. Although research is preliminary, cryosurgery is fast becoming an alternative treatment method for HCC or liver tumors. Here, we review the mechanisms of liver tumor cryoablation, cryoablation program selection, clinical efficiency, and complications following treatment.

[1]  Hong Wang,et al.  Tumour seeding after percutaneous cryoablation for hepatocellular carcinoma. , 2012, World journal of gastroenterology.

[2]  Aleodor Andea,et al.  Cryotherapy for breast fibroadenomas. , 2005, Radiology.

[3]  Yanqiao Zhang,et al.  Comparison of percutaneous cryosurgery and surgical resection for the treatment of small hepatocellular carcinoma , 2013, Oncology letters.

[4]  Kecheng Xu,et al.  Comparison of dual- and triple-freeze protocols for hepatic cryoablation in a Tibet pig model. , 2012, Cryobiology.

[5]  R. Shapiro,et al.  Cryoablation of unresectable malignant liver tumors. , 1996, American journal of surgery.

[6]  A A Gage,et al.  Freezing injury to large blood vessels in dogs. With comments on the effect of experimental freezing of bile ducts. , 1967, Surgery.

[7]  D. Irimia,et al.  Kinetics of intracellular ice formation in one-dimensional arrays of interacting biological cells. , 2005, Biophysical journal.

[8]  Ke-cheng Xu,et al.  Percutaneous cryosurgery for the treatment of hepatic colorectal metastases. , 2008, World journal of gastroenterology.

[9]  B. S. Paul J. Cozzi M.B.,et al.  Thrombocytopenia after hepatic cryotherapy for colorectal metastases: Correlates with hepatocellular injury , 2004, World Journal of Surgery.

[10]  M. Shahid,et al.  Analysis of Significant Decrease in Platelet Count and Thrombocytopenia, Graded According to NCI-CTC, as Prognostic Risk Markers for Mortality and Morbidity , 2011, Journal of pediatric hematology/oncology.

[11]  J. Neifeld,et al.  Biochemical, hematologic, and immunologic alterations following hepatic cryotherapy. , 1998, Seminars in surgical oncology.

[12]  Wendy Lim,et al.  The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. , 2011, Chest.

[13]  W. S. Wong,et al.  Cryosurgery as a treatment for advanced stage hepatocellular carcinoma , 1998, Cancer.

[14]  T. Sarantou,et al.  Complications of hepatic cryosurgery. , 1998, Seminars in surgical oncology.

[15]  Y. Iwashita,et al.  A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer , 2003, Cancer Immunology, Immunotherapy.

[16]  Qiang Zhou,et al.  Sequential use of transarterial chemoembolization and percutaneous cryosurgery for hepatocellular carcinoma. , 2009, World journal of gastroenterology.

[17]  L. Niu,et al.  Percutaneous cryoablation in combination with ethanol injection for unresectable hepatocellular carcinoma. , 2003, World journal of gastroenterology.

[18]  W. Lau,et al.  Ultrasound-guided percutaneous cryotherapy of hepatocellular carcinoma. , 2011, International journal of surgery.

[19]  Wei-Chen Lee,et al.  Vaccination of Advanced Hepatocellular Carcinoma Patients with Tumor Lysate-Pulsed Dendritic Cells: A Clinical Trial , 2005, Journal of immunotherapy.

[20]  Kecheng Xu,et al.  Diagnosis and treatment of coagulopathy following percutaneous cryoablation of liver tumors: experience in 372 patients. , 2013, Cryobiology.

[21]  M. Sabel,et al.  Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. , 2009, Cryobiology.

[22]  P. Mazur.  Freezing of living cells: mechanisms and implications. , 1984, The American journal of physiology.

[23]  P. Littrup,et al.  CT-guided percutaneous cryotherapy of renal masses. , 2007, Journal of vascular and interventional radiology : JVIR.

[24]  Kemal Tuncali,et al.  Three-dimensional assessment of MRI-guided percutaneous cryotherapy of liver metastases. , 2004, AJR. American journal of roentgenology.

[25]  D L Morton,et al.  Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. , 2000, Archives of surgery.

[26]  L. Niu,et al.  Percutaneous comprehensive cryoablation for metastatic hepatocellular cancer. , 2013, Cryobiology.

[27]  J Bastacky,et al.  The process of freezing and the mechanism of damage during hepatic cryosurgery. , 1988, Cryobiology.

[28]  Kecheng Xu,et al.  Alleviating the pain of unresectable hepatic tumors by percutaneous cryoablation: Experience in 73 patients. , 2013, Cryobiology.

[29]  Christopher Long,et al.  Case Report of Fatal Complication in Prostatic Cryotherapy: First Reported Death Due to Argon Gas Emboli , 2012, The American journal of forensic medicine and pathology.

[30]  T. Ravikumar,et al.  Induction of apoptosis in human colon carcinoma cells HT29 by sublethal cryo‐injury: Mediation by cytochrome c release , 2001, International journal of cancer.

[31]  S. Paggi,et al.  Sorafenib in Advanced Hepatocellular Carcinoma , 2008 .

[32]  J. Baust,et al.  Cryosurgical Effects on Growing Vessels , 1999, The American surgeon.

[33]  J. Hinshaw,et al.  Cryoablation for liver cancer. , 2007, Techniques in vascular and interventional radiology.

[34]  M. Menger,et al.  Aprotinin inhibits local platelet trapping and improves tissue destruction in hepatic cryosurgery. , 2004, Surgery.

[35]  A. Sauaia,et al.  Refractory postinjury thrombocytopenia is associated with multiple organ failure and adverse outcomes. , 2011, The Journal of trauma.

[36]  A. Schmitt-Graeff,et al.  Hepatic Cryotherapy Involving the Vena cava , 2003, European Surgical Research.

[37]  J. Bischof,et al.  Investigation of the mechanism and the effect of cryoimmunology in the Copenhagen rat. , 2001, Cryobiology.

[38]  H. Blum,et al.  Primary hepatocellular carcinoma. , 1991, The New England journal of medicine.

[39]  John C Bischof,et al.  The cryobiology of cryosurgical injury. , 2002, Urology.

[40]  E. Sigurdson,et al.  Liver-directed therapies for patients with primary liver cancer and hepatic metastases , 2006, Current treatment options in oncology.

[41]  A. Burroughs,et al.  Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum. , 2004, The Lancet. Oncology.

[42]  [Cryosurgery combined with Iodine-125 seed implantation in the treatment of unresectable lung cancer.]. , 2008, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[43]  R. Dick,et al.  Treatment of small hepatocellular carcinomas , 1992, The Lancet.

[44]  D. Kerr,et al.  A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma , 2009, Hepatology.

[45]  I. Schmidt-Wolf,et al.  Combining cytokine-induced killer cells with vaccination in cancer immunotherapy: more than one plus one? , 2011, Leukemia research.

[46]  L. Ellis,et al.  Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. , 1999, American journal of surgery.

[47]  Yinying Lu,et al.  Efficacy of argon-helium cryosurgical ablation on primary hepatocellular carcinoma: a pilot clinical study. , 2009, Ai zheng = Aizheng = Chinese journal of cancer.

[48]  D. Morris,et al.  Laboratory and animal model evaluation of the Cryotech LCS 2000 in hepatic cryotherapy. , 1993, Cryobiology.

[49]  Giovanni Simonetti,et al.  Percutaneous Cryoablation of Small Hepatocellular Carcinoma with US Guidance and CT Monitoring: Initial Experience , 2008, CardioVascular and Interventional Radiology.

[50]  L. Niu,et al.  Combination treatment with comprehensive cryoablation and immunotherapy in metastatic hepatocellular cancer. , 2013, World journal of gastroenterology.

[51]  M. Menger,et al.  Local Platelet Trapping as the Cause of Thrombocytopenia after Hepatic Cryotherapy , 2005, World Journal of Surgery.

[52]  D. Whittaker.  Repeat freeze cycles in cryosurgery of oral tissues , 1975, British Dental Journal.

[53]  A. Gage,et al.  Experimental cryosurgery investigations in vivo. , 2009, Cryobiology.

[54]  P. Rovere-Querini,et al.  Tumor destruction and in situ delivery of antigen presenting cells promote anti-neoplastic immune responses: implications for the immunotherapy of pancreatic cancer. , 2004, JOP : Journal of the pancreas.

[55]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[56]  Bjørn Edwin,et al.  Percutaneous cryoablation of colorectal liver metastases: potentiated by two consecutive freeze-thaw cycles. , 2003, Cryobiology.

[57]  A. Gage,et al.  Mechanisms of tissue injury in cryosurgery. , 1998, Cryobiology.

[58]  Yinying Lu,et al.  Outcomes of ultrasound-guided percutaneous argon-helium cryoablation of hepatocellular carcinoma , 2011, Journal of hepato-biliary-pancreatic sciences.